Peptest & Reflux Updates
Professor Peter Dettmar Co-Edits Annals of Esophagus Special
Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal.read moreProton Pump Inhibitor Use Linked to Increased Asthma Risk in Children
Children that take proton pump inhibitors medication (PPIs) are more likely to have asthma than those that don’t, a study published in JAMA Pediatrics...read moreGERD review by Professor Dettmar in Annals of Esophagus
Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international...read morePhysiotherapists at NHS Hospital use Peptest in respiratory clinics
Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.read moreVolunteers wanted for study into trigger foods for reflux
Do you suffer from reflux-related symptoms? Northumbria University is looking for recruits to take part in a study investigating foods that trigger reflux and...read morePeptest at laryngopharyngeal reflux symposium in China
Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth.read morePeptest could help eliminate unnecessary use of PPIs
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...read moreDiet and lifestyle can impact reflux symptoms in women
Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...read morePeople with oesophagus problems may be vulnerable to COVID ‘by swallowing’ – study claims
People with problems in the upper gastrointestinal (GI) tract may be vulnerable to infection after ‘swallowing’ the Covid-19 virus, a new study has suggested....read more
Professor Peter Dettmar Co-Edits Annals of Esophagus Special
Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal.read moreGERD review by Professor Dettmar in Annals of Esophagus
Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international...read morePhysiotherapists at NHS Hospital use Peptest in respiratory clinics
Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.read morePeptest at laryngopharyngeal reflux symposium in China
Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth.read morePeptest in virtual conference of China gastro experts
Professor Peter Dettmar has provided insight into the diagnosis and treatment of reflux disease to a virtual conference of key opinion leaders in China.read moreCould Peptest help triage non-urgent reflux cases?
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed.read moreRestech unveils ‘PepsinCheck by Peptest’ in the US
Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’.read morePeptest labs to reopen for reflux testing
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus...read moreCovid-19: a coronavirus update
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will...read more
Physiotherapists at NHS Hospital use Peptest in respiratory clinics
Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.read morePeptest could help eliminate unnecessary use of PPIs
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...read moreSelf-referral reflux test using Peptest
Peptest is a useful, non-invasive diagnostic test for self-diagnosing reflux related symptoms, a study published in the EC Gastroenterology and Digestive System journal has...read moreStudy compares ‘simpler’ Peptest to ‘invasive’ 24-hour pH monitoring
Salivary pepsin detection is hailed a ‘simpler, more cost-effective and less traumatic universal first-line alternative’ to 24-hour pH monitoring in diagnosing laryngopharyngeal reflux disease...read moreEye exams could help reflux patients
Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study.read moreStudy says Peptest is ‘useful for LPR diagnosis’
Laryngopharyngeal reflux (LPR), when gastric contents refluxes into the larynx/pharynx, can be diagnosed using a salivary pepsin test, researchers say.read moreJapan non-erosive reflux study utilises Peptest
Peptest has been identified as a ‘promising’ way to clinically diagnose patients with non-erosive reflux that doesn’t respond to medication in Japan study.read more
Proton Pump Inhibitor Use Linked to Increased Asthma Risk in Children
Children that take proton pump inhibitors medication (PPIs) are more likely to have asthma than those that don’t, a study published in JAMA Pediatrics...read moreVolunteers wanted for study into trigger foods for reflux
Do you suffer from reflux-related symptoms? Northumbria University is looking for recruits to take part in a study investigating foods that trigger reflux and...read moreDiet and lifestyle can impact reflux symptoms in women
Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...read moreLong-term PPI usage linked to diabetes
Regular use of PPIs increases risk of developing type 2 diabetes by 24 per cent, an observational study published in Gut journal suggests.read moreCan training to sleep on the left help tackle reflux?
Sleeping left-side down with your head and torso elevated is often suggested as a way of preventing night-time reflux.read moreCoffee, tea & soda leads to ‘increased reflux’ symptoms in older women
Middle-aged women suffering from heartburn or regurgitation should avoid drinking coffee, tea or soda and stick to water, a new study suggests.read moreSuffer from reflux? 12 lifestyle changes that can help with your symptoms
People with reflux disease often discover that there are certain things they do which make their symptoms worse. Making a few lifestyle modifications could...read more
Peptest could help eliminate unnecessary use of PPIs
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...read moreDiet and lifestyle can impact reflux symptoms in women
Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...read moreWhat is the RefluxStop implant?
Medtech firm Implantica says its new RefluxStop device for treating acid reflux can ‘eliminate the need for proton-pump inhibitors (PPIs)’.read moreWhat is Stretta therapy for treating reflux?
The Stretta system uses a special catheter or tube to deliver low-power and low-temperature radiofrequency energy to the muscle tissues in the LOS.read moreProton Pump Inhibitors (PPIs) Explained
Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in the world - here's our at-a-glance guide to PPIs.read moreIQoro: could this oral device help treat reflux?
Iqoro - a device that helps to strengthens the oesophagus and diaphragm - has been recognised by the NHS healthcare watchdog for relieving symptoms...read moreCan cashew gum help tackle reflux?
A new study ‘Cashew gum, a biopolymer, topically protects oesophageal mucosa in nonerosive reflux disease: A promising translational study’ has looked at whether cashew...read moreZantac heartburn drugs recalled: what you need to know
Doctors in the UK have been told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a ‘precautionary measure’.read moreSeaweed can help with reflux: study shows
Alginate, a type of fibre found in seaweed, has been used to help with the symptoms of reflux disease for many years. Alginates naturally...read more
Peptest™ is a single use in-vitro diagnostic device not for ingestion. It conforms to the European Directive 98/79/EC on in-vitro Diagnostic Medical Devices; this is shown by the CE mark of conformity.
Peptest™ kits are manufactured in the UK by RDBiomed Limited - a private limited company registered in England and Wales with number 06979218.
RDBiomed Limited
Daisy Building (2nd Floor)
Castle Hill Hospital
Castle Road
Cottingham
HU16 5JQ, UK
VAT Number: GB 990 1918 96
Explore
Follow
